Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2–Low A double-blind placebo-controlled phase III trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results